Potential probiotics for regulation of the gut-lung axis to prevent or alleviate influenza in vulnerable populations

10.1016/j.jtcme.2022.08.004

Yi-Hsiang Wang；Aniket Limaye；Je-Ruei Liu；Tai-Na Wu

Influenza ； Microbiota ； Gut-lung axis ； Probiotics ； Immunomodulatory

Journal of Traditional and Complementary Medicine

13卷2期（2023 / 03 / 01）

161 - 169

英文

Influenza, also known as "flu", is an infectious disease caused by influenza viruses. Three types of influenza virus, A, B, and C, are able to infect humans. In most people, influenza causes mild symptoms, but it can also induce severe complications and death. Annual influenza vaccines are currently the main intervention used to minimize mortality and morbidity. However, vaccination frequently fails to provide adequate protection, especially in the elderly. Traditional flu vaccine targets hemagglutinin to prevent virus infection, but the constant mutation of hemagglutinin means that it is a challenge to develop vaccines quickly enough to keep up with mutations. Thus, other methods of curbing influenza incidence would be welcomed, especially for vulnerable populations. Although influenza viruses primarily infect the respiratory tract, influenza virus infection also induces intestinal dysbiosis. Through gut microbiota-derived secreted products and the circulating immune cells, gut microbiota can affect pulmonary immunity. The crosstalk between the respiratory tract and gut microbiota, termed the "gut-lung axis", is observed in the regulation of immune responses against influenza virus infection or inflammation-induced lung damage, indicating the possibility of using probiotics to prevent influenza virus infection or alleviate respiratory symptoms. In this review, we summarize the current findings on the antiviral functions of particular probiotics and/or combinations and discuss the antiviral mechanisms and immunomodulatory activities of probiotics in vitro, in mice, and in humans. Clinical studies show pro-biotic supplements can provide health benefits, not only to the elderly or children with compromised immune systems, but also to young- and middle-aged adults.

1. Alonso, VR,Guarner, F(2013).Linking the gut microbiota to human health.Br J Nutr,109(S2),S21-S26.
2. Arena, MP,Capozzi, V,Russo, P,Drider, D,Spano, G,Fiocco, D(2018).Immunobiosis and probiosis: antimicrobial activity of lactic acid bacteria with a focus on their antiviral and antifungal properties.Appl Microbiol Biotechnol,102(23),9949-9958.
3. Bradley, KC,Finsterbusch, K,Schnepf, D(2019).Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection.Cell Rep,28(1),245-256.e244.
4. Budden, KF,Gellatly, SL,Wood, DL(2017).Emerging pathogenic links between microbiota and the gut-lung axis.Nat Rev Microbiol,15(1),55-63.
5. Chen, HW,Liu, PF,Liu, YT(2016).Nasal commensal Staphylococcus epidermidis counteracts influenza virus.Sci Rep,6,27870.
6. Choi, UY,Kang, J-S,Hwang, YS,Kim, Y-J(2015).Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases.Exp Mol Medicine,47(3),e144-e144.
7. Chong, HX,Yusoff, NAA,Hor, YY(2019).Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: a randomized, double-blind, placebo-controlled study.J Dairy Sci.,102(6),4783-4797.
8. Deriu, E,Boxx, GM,He, X(2016).Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I interferons.PLoS Pathog,12(5),e1005572.
9. Dickson, RP,Singer, BH,Newstead, MW(2016).Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome.Nature microbiology,1(10),16113.
10. Edouard, S,Million, M,Bachar, D(2018).The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens.Eur J Clin Microbiol I official publication of the European Society of Clinical Microbiology,37(9),1725-1733.
11. Ermolenko, EI,Desheva, YA,Kolobov, AA,Kotyleva, MP,Sychev, IA,Suvorov, AN(2019).Anti-influenza activity of enterocin B in vitro and protective effect of bacteriocinogenic enterococcal probiotic strain on influenza infection in mouse model.Probiotics Antimicro,11(2),705-712.
12. Fujita, R,Iimuro, S,Shinozaki, T(2013).Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population.Am J Infect Control,41(12),1231-1235.
13. Gao, X,Huang, L,Zhu, L,Mou, C,Hou, Q,Yu, Q(2016).Inhibition of H9N2 virus invasion into dendritic cells by the S-layer protein from L. acidophilus ATCC 4356.Front Cell Infect Microbiol,6,137.
14. Garaiova, I,Muchova, J,Nagyova, Z(2015).Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study.Eur J Clin Nutr,69(3),373-379.
15. Gleeson, M,Bishop, NC,Oliveira, M,McCauley, T,Tauler, P,Lawrence, C(2012).Effects of a Lactobacillus salivarius probiotic intervention on infection, cold symptom duration and severity, and mucosal immunity in endurance athletes.Int J Sport Nutr Exerc Metabol,22(4),235-242.
16. Goto, H,Sagitani, A,Ashida, N(2013).Anti-influenza virus effects of both live and non-live Lactobacillus acidophilus L-92 accompanied by the activation of innate immunity.Br J Nutr,110(10),1810-1818.
17. Groves, HT,Cuthbertson, L,James, P,Moffatt, MF,Cox, MJ,Tregoning, JS(2018).Respiratory disease following viral lung infection alters the murine gut microbiota.Front Immunol,9,182.
18. Gu, S,Chen, Y,Wu, Z(2020).Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza.Clin Infect Dis : an official publication of the Infectious Diseases Society of America,71(10),2669-2678.
19. Houghton, LA,Lee, AS,Badri, H,DeVault, KR,Smith, JA(2016).Respiratory disease and the oesophagus: reflux, reflexes and microaspiration.Nat Rev Gastroenterol Hepatol,13(8),445-460.
20. Ichinohe, T,Pang, IK,Kumamoto, Y(2011).Microbiota regulates immune defense against respiratory tract influenza A virus infection.Proc. Natl. Acad. Sci. U.S.A.,108(13),5354-5359.
21. Ishikawa, H,Kuno, Y,Kohda, C,Sasaki, H,Nagashima, R,Iyoda, M(2022).Exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 prevent influenza virus infection and attenuate secondary bacterial infection risk.Lett Appl Microbiol,74,632-639.
22. Iuliano, AD,Roguski, KM,Chang, HH(2018).Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.Lancet,391(10127),1285-1300.
23. Kalil, AC,Thomas, PG(2019).Influenza virus-related critical illness: pathophysiology and epidemiology.Crit Care,23(1),258.
24. Kanmani, P,Albarracin, L,Kobayashi, H(2018).Exopolysaccharides from Lactobacillus delbrueckii OLL1073R-1 modulate innate antiviral immune response in porcine intestinal epithelial cells.Mol Immunol,93,253-265.
25. Kassaa, IA,Hober, D,Hamze, M,Chihib, NE,Drider, D(2014).Antiviral potential of lactic acid bacteria and their bacteriocins.Probiotics Antimicro,6(3-4),177-185.
26. Kumpu, M,Kekkonen, RA,Kautiainen, H(2012).Milk containing probiotic Lacto-bacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial.Eur J Clin Nutr,66(9),1020-1023.
27. Kumpu, M,Lehtoranta, L,Roivainen, M(2013).The use of the probiotic Lactobacillus rhamnosus GG and viral findings in the nasopharynx of children attending day care.J Med Virol,85(9),1632-1638.
28. La Fata, G,Weber, P,Mohajeri, MH(2018).Probiotics and the gut immune system: indirect regulation.Probiotics Antimicro,10(1),11-21.
29. Lee, N-K,Paik, H-D.(2021).Prophylactic effects of probiotics on respiratory viruses including COVID-19: a review.Food Sci Biotechnol,30(6),773-781.
30. Lei, WT,Shih, PC,Liu, SJ,Lin, CY,Yeh, TL(2017).Effect of probiotics and prebiotics on immune response to influenza vaccination in adults: a systematic review and meta-analysis of randomized controlled trials.Nutrients,9(11)
31. Lepage, P,Leclerc, MC,Joossens, M(2013).A metagenomic insight into our gut's microbiome.Gut,62(1),146-158.
32. Liu, X,Cao, S,Zhang, X(2015).Modulation of gut microbiota-brain axis by probiotics, prebiotics, and diet.J Agric Food Chem,63(36),7885-7895.
33. Lu, W,Fang, Z,Liu, X(2021).The potential role of probiotics in protection against influenza A virus infection in mice.Foods,10(4),902.
34. Nakayama, Y,Moriya, T,Sakai, F(2014).Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice.Sci Rep-uk,4(1),4638.
35. Oslund, KL,Baumgarth, N(2011).Influenza-induced innate immunity: regulators of viral replication, respiratory tract pathology & adaptive immunity.Future Virol,6(8),951-962.
36. Park, M-K,Ngo, V,Kwon, Y-M(2013).Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity.PLoS One,8(10),e75368.
37. Paules, C,Subbarao, K(2017).Influenza.Lancet,390(10095),697-708.
38. Pu, FF,Guo, Y,Li, M(2017).Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial.Clin Interv Aging,12,1223-1231.
39. Reber, AJ,Chirkova, T,Kim, JH(2012).Immunosenescence and challenges of vaccination against influenza in the aging population.Aging and disease,3(1),68-90.
40. Schoggins, JW(2014).Interferon-stimulated genes: roles in viral pathogenesis.Curr Opin Virol,6,40-46.
41. Schoggins, JW,Rice, CM(2011).Interferon-stimulated genes and their antiviral effector functions.Curr Opin Virol,1(6),519-525.
42. Serkedjieva, J,Danova, S,Ivanova, I(2000).Antiinfluenza virus activity of a bacteriocin produced by Lactobacillus delbrueckii.Appl Biochem Biotechnol,88(1-3),285-298.
43. Shida, K,Sato, T,Iizuka, R(2017).Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers.Eur J Nutr,56(1),45-53.
44. Shinya, K,Ito, M,Makino, A(2012).The TLR4-TRIF pathway protects against H5N1 influenza virus infection.J Virol,86(1),19-24.
45. Simon, AK,Hollander, GA,McMichael, A(2015).Evolution of the immune system in humans from infancy to old age.Proceedings. Biological sciences,282(1821),20143085.
46. Smith, TJ,Rigassio-Radler, D,Denmark, R,Haley, T,Touger-Decker, R(2013).Effect of Lactobacillus rhamnosus LGG(R) and Bifidobacterium animalis ssp. lactis BB-12(R) on health-related quality of life in college students affected by upper respiratory infections.Br J Nutr,109(11),1999-2007.
47. Taipale, T,Pienihakkinen, K,Isolauri, E(2011).Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.Br J Nutr,105(3),409-416.
48. Takeda, S,Takeshita, M,Kikuchi, Y(2011).Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice: alleviation of influenza infection by its immunomodulatory activity through intestinal immunity.Int Immunopharm,11(12),1976-1983.
49. Tonetti, FR,Islam, A,Vizoso-Pinto, MG,Takahashi, H,Kitazawa, H,Villena, J(2020).Nasal priming with immunobiotic lactobacilli improves the adaptive immune response against influenza virus.Int Immunopharm,78,106115.
50. Trompette, A,Gollwitzer, ES,Pattaroni, C(2018).Dietary fiber confers protection against flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism.Immunity,48(5),992-1005e1008.
51. Villena, J,Vizoso-Pinto, MG,Kitazawa, H(2016).Intestinal innate antiviral immunity and immunobiotics: beneficial effects against rotavirus infection.Front Immunol,7,563.
52. Waki, N,Yajima, N,Suganuma, H(2014).Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection.Lett Appl Microbiol,58(1),87-93.
53. Wang, B,Hylwka, T,Smieja, M,Surrette, M,Bowdish, DME,Loeb, M(2018).Probiotics to prevent respiratory infections in nursing homes: a pilot randomized controlled trial.J Am Geriatr Soc.,66(7),1346-1352.
54. Wang, J,Li, F,Wei, H,Lian, ZX,Sun, R,Tian, Z(2014).Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 celldependent inflammation.J Exp Med,211(12),2397-2410.
55. Wang, Z,Chai, W,Burwinkel, M(2013).Inhibitory influence of Enterococcus faecium on the propagation of swine influenza A virus in vitro.PLoS One,8(1),e53043.
56. Watanabe, T,Hayashi, K,Kan, T,Ohwaki, M,Kawahara, T(2021).Anti-Influenza virus effects of Enterococcus faecalis KH2 and Lactobacillus plantarum SNK12 RNA.Biosci Microbiota Food Heal,40(1),43-49.
57. Wong, SS,Webby, RJ(2013).Traditional and new influenza vaccines.Clin Microbiol Rev,26(3),476-492.
58. Yamamoto, Y,Saruta, J,Takahashi, T(2019).Effect of ingesting yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 on influenza virusbound salivary IgA in elderly residents of nursing homes: a randomized controlled trial.Acta Odontol Scand,77(7),517-524.
59. Yeo, J-M,Lee, H-J,Kim, J-W(2014).Lactobacillus fermentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response.Int Immunopharm,18(1),50-54.
60. Yildiz, S,Mazel-Sanchez, B,Kandasamy, M,Manicassamy, B,Schmolke, M(2018).Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis.Microbiome,6(1),9.
61. Zhang, H,Yeh, C,Jin, Z(2018).Prospective study of probiotic supplementation results in immune stimulation and improvement of upper respiratory infection rate.Synth Syst Biotechnol,3(2),113-120.